These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 33009760)

  • 1. Compassionate Drug Use - Time Arising for a New Law in Bulgaria in the Era of COVID-19.
    Dzhafer N; Papathanasiou JV
    Folia Med (Plovdiv); 2020 Sep; 62(3):592-596. PubMed ID: 33009760
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Have we found the panacea to COVID-19 with remdesivir, an old but newly packaged drug?
    Thalha AMM; Lee YY; Besari A; Omar SFS
    J R Coll Physicians Edinb; 2020 Jun; 50(2):159-161. PubMed ID: 32568289
    [No Abstract]   [Full Text] [Related]  

  • 3. Compassionate Use of Remdesivir for Patients with Severe Covid-19.
    Grein J; Ohmagari N; Shin D; Diaz G; Asperges E; Castagna A; Feldt T; Green G; Green ML; Lescure FX; Nicastri E; Oda R; Yo K; Quiros-Roldan E; Studemeister A; Redinski J; Ahmed S; Bernett J; Chelliah D; Chen D; Chihara S; Cohen SH; Cunningham J; D'Arminio Monforte A; Ismail S; Kato H; Lapadula G; L'Her E; Maeno T; Majumder S; Massari M; Mora-Rillo M; Mutoh Y; Nguyen D; Verweij E; Zoufaly A; Osinusi AO; DeZure A; Zhao Y; Zhong L; Chokkalingam A; Elboudwarej E; Telep L; Timbs L; Henne I; Sellers S; Cao H; Tan SK; Winterbourne L; Desai P; Mera R; Gaggar A; Myers RP; Brainard DM; Childs R; Flanigan T
    N Engl J Med; 2020 Jun; 382(24):2327-2336. PubMed ID: 32275812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Compassionate remdesivir treatment of severe Covid-19 pneumonia in intensive care unit (ICU) and Non-ICU patients: Clinical outcome and differences in post-treatment hospitalisation status.
    Antinori S; Cossu MV; Ridolfo AL; Rech R; Bonazzetti C; Pagani G; Gubertini G; Coen M; Magni C; Castelli A; Borghi B; Colombo R; Giorgi R; Angeli E; Mileto D; Milazzo L; Vimercati S; Pellicciotta M; Corbellino M; Torre A; Rusconi S; Oreni L; Gismondo MR; Giacomelli A; Meroni L; Rizzardini G; Galli M
    Pharmacol Res; 2020 Aug; 158():104899. PubMed ID: 32407959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compassionate Use of Remdesivir in Covid-19.
    Fätkenheuer G; Lundgren J
    N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412706
    [No Abstract]   [Full Text] [Related]  

  • 6. Compassionate Use of Remdesivir in Covid-19.
    Bonovas S; Piovani D
    N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412705
    [No Abstract]   [Full Text] [Related]  

  • 7. Compassionate Use of Remdesivir in Covid-19.
    Hoffmann C
    N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412707
    [No Abstract]   [Full Text] [Related]  

  • 8. Compassionate Use of Remdesivir in Covid-19.
    Wu J; Wu B; Lai T
    N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412708
    [No Abstract]   [Full Text] [Related]  

  • 9. Compassionate Use of Remdesivir in Covid-19. Reply.
    Grein J; Myers RP; Brainard D
    N Engl J Med; 2020 Jun; 382(25):e101. PubMed ID: 32412709
    [No Abstract]   [Full Text] [Related]  

  • 10. Remdesivir emergency approvals: a comparison of the U.S., Japanese, and EU systems.
    Saint-Raymond A; Sato J; Kishioka Y; Teixeira T; Hasslboeck C; Kweder SL
    Expert Rev Clin Pharmacol; 2020 Oct; 13(10):1095-1101. PubMed ID: 32909843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid review for the anti-coronavirus effect of remdesivir.
    Li Z; Wang X; Cao D; Sun R; Li C; Li G
    Drug Discov Ther; 2020; 14(2):73-76. PubMed ID: 32378648
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arguments in favour of remdesivir for treating SARS-CoV-2 infections.
    Ko WC; Rolain JM; Lee NY; Chen PL; Huang CT; Lee PI; Hsueh PR
    Int J Antimicrob Agents; 2020 Apr; 55(4):105933. PubMed ID: 32147516
    [No Abstract]   [Full Text] [Related]  

  • 13. Missed Opportunities on Emergency Remdesivir Use.
    Sarpatwari A; Kaltenboeck A; Kesselheim AS
    JAMA; 2020 Jul; 324(4):331-332. PubMed ID: 32579163
    [No Abstract]   [Full Text] [Related]  

  • 14. Policy Implications of the Orphan Drug Designation for Remdesivir to Treat COVID-19.
    Chua KP; Conti RM
    JAMA Intern Med; 2020 Oct; 180(10):1273-1274. PubMed ID: 32804187
    [No Abstract]   [Full Text] [Related]  

  • 15. Remdesivir against COVID-19 and Other Viral Diseases.
    Malin JJ; Suárez I; Priesner V; Fätkenheuer G; Rybniker J
    Clin Microbiol Rev; 2020 Dec; 34(1):. PubMed ID: 33055231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Remdesivir in COVID-19: A critical review of pharmacology, pre-clinical and clinical studies.
    Singh AK; Singh A; Singh R; Misra A
    Diabetes Metab Syndr; 2020; 14(4):641-648. PubMed ID: 32428865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergency Use Authorization of Remdesivir: The Need for a Transparent Distribution Process.
    Ison MG; Wolfe C; Boucher HW
    JAMA; 2020 Jun; 323(23):2365-2366. PubMed ID: 32407438
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatic Disorders With the Use of Remdesivir for Coronavirus 2019.
    Montastruc F; Thuriot S; Durrieu G
    Clin Gastroenterol Hepatol; 2020 Nov; 18(12):2835-2836. PubMed ID: 32721580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiviral treatment for COVID-19: the evidence supporting remdesivir.
    Richardson C; Bhagani S; Pollara G
    Clin Med (Lond); 2020 Nov; 20(6):e215-e217. PubMed ID: 32863273
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expanded Umbilical Cord Mesenchymal Stem Cells (UC-MSCs) as a Therapeutic Strategy in Managing Critically Ill COVID-19 Patients: The Case for Compassionate Use.
    Atluri S; Manchikanti L; Hirsch JA
    Pain Physician; 2020 Mar; 23(2):E71-E83. PubMed ID: 32214286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.